Ballardini M - Search Results

Year	Number of Results
1963	1
1992	1
1995	1
2003	1
2004	1
2005	1
2006	3
2007	2
2008	6
2009	7
2010	1
2011	2
2012	2
2013	4
2014	2
2015	3
2016	3
2017	3
2018	4
2019	5
2020	2
2021	1
2022	2
2023	3
2024	2
2025	0

1

First-Line Treatment of Older Patients with CLL: A New Approach in the Chemo-Free Era.

Urso A, Cavazzini F, Ballardini MP, Gambara S, Consolo S, Rigolin GM, Cuneo A. Urso A, et al. Among authors: ballardini mp. Cancers (Basel). 2023 Jul 29;15(15):3859. doi: 10.3390/cancers15153859. Cancers (Basel). 2023. PMID: 37568676 Free PMC article. Review.

2

Detection of KPC-216, a Novel KPC-3 Variant, in a Clinical Isolate of Klebsiella pneumoniae ST101 Co-Resistant to Ceftazidime-Avibactam and Cefiderocol.

Giufrè M, Errico G, Del Grosso M, Pagnotta M, Palazzotti B, Ballardini M, Pantosti A, Meledandri M, Monaco M. Giufrè M, et al. Among authors: ballardini m. Antibiotics (Basel). 2024 May 29;13(6):507. doi: 10.3390/antibiotics13060507. Antibiotics (Basel). 2024. PMID: 38927174 Free PMC article.

3

NEUROPATHOLOGIC FINDINGS IN CETACEANS STRANDED IN ITALY (2002-14).

Pintore MD, Mignone W, Di Guardo G, Mazzariol S, Ballardini M, Florio CL, Goria M, Romano A, Caracappa S, Giorda F, Serracca L, Pautasso A, Tittarelli C, Petrella A, Lucifora G, Di Nocera F, Uberti BD, Corona C, Casalone C, Iulini B. Pintore MD, et al. Among authors: ballardini m. J Wildl Dis. 2018 Apr;54(2):295-303. doi: 10.7589/2017-02-035. Epub 2018 Jan 25. J Wildl Dis. 2018. PMID: 29369721

4

Outcomes and prognostic factors in 3306 patients with relapsed/refractory chronic lymphocytic leukemia treated with ibrutinib outside of clinical trials: A nationwide study.

Rigolin GM, Olimpieri PP, Summa V, Celant S, Scarfò L, Ballardini MP, Urso A, Gambara S, Cavazzini F, Ghia P, Cuneo A, Russo P. Rigolin GM, et al. Among authors: ballardini mp. Hemasphere. 2024 Oct 8;8(10):e70017. doi: 10.1002/hem3.70017. eCollection 2024 Oct. Hemasphere. 2024. PMID: 39380844 Free PMC article.

5

Immigration as the main driver of population dynamics in a cryptic cetacean.

Tenan S, Moulins A, Tepsich P, Bocconcelli A, Verga A, Ballardini M, Nani B, Papi D, Motta G, Aguilar AS, Rosso M. Tenan S, et al. Among authors: ballardini m. Ecol Evol. 2023 Feb 11;13(2):e9806. doi: 10.1002/ece3.9806. eCollection 2023 Feb. Ecol Evol. 2023. PMID: 36789337 Free PMC article.

6

Streptococcus pneumoniae primary peritonitis mimicking acute appendicitis in an immunocompetent patient: a case report and review of the literature.

Cortese F, Fransvea P, Saputelli A, Ballardini M, Baldini D, Gioffre A, Marcello R, Sganga G. Cortese F, et al. Among authors: ballardini m. J Med Case Rep. 2019 Apr 28;13(1):126. doi: 10.1186/s13256-019-2038-3. J Med Case Rep. 2019. PMID: 31029142 Free PMC article. Review.

7

Outcomes in patients with chronic lymphocytic leukemia and TP53 aberration who received first-line ibrutinib: a nationwide registry study from the Italian Medicines Agency.

Rigolin GM, Olimpieri PP, Summa V, Celant S, Scarfò L, Tognolo L, Ballardini MP, Urso A, Sessa M, Gambara S, Cura F, Fortini M, Ghia P, Cuneo A, Russo P. Rigolin GM, et al. Among authors: ballardini mp. Blood Cancer J. 2023 Jun 28;13(1):99. doi: 10.1038/s41408-023-00865-z. Blood Cancer J. 2023. PMID: 37380630 Free PMC article.

8

First evidence of pyrethroid resistance in Italian populations of West Nile virus vector Culex pipiens.

Pichler V, Giammarioli C, Bellini R, Veronesi R, Arnoldi D, Rizzoli A, Lia RP, Otranto D, Ballardini M, Cobre P, Serini P, Della Torre A, Caputo B. Pichler V, et al. Among authors: ballardini m. Med Vet Entomol. 2022 Sep;36(3):390-395. doi: 10.1111/mve.12573. Epub 2022 Apr 9. Med Vet Entomol. 2022. PMID: 35396754 Free PMC article.

9

Complement Activation Profile in Myasthenia Gravis Patients: Perspectives for Tailoring Anti-Complement Therapy.

Iacomino N, Vanoli F, Frangiamore R, Ballardini M, Scandiffio L, Bortone F, Andreetta F, Baggi F, Bernasconi P, Antozzi C, Cavalcante P, Mantegazza R. Iacomino N, et al. Among authors: ballardini m. Biomedicines. 2022 Jun 9;10(6):1360. doi: 10.3390/biomedicines10061360. Biomedicines. 2022. PMID: 35740382 Free PMC article.

10

Identification of L169P mutation in the omega loop of KPC-3 after a short course of ceftazidime/avibactam.

Venditti C, Nisii C, Ballardini M, Meledandri M, Di Caro A. Venditti C, et al. Among authors: ballardini m. J Antimicrob Chemother. 2019 Aug 1;74(8):2466-2467. doi: 10.1093/jac/dkz201. J Antimicrob Chemother. 2019. PMID: 31086956 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

59 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

59 results

Results by year